The Clinical Development team develops new therapeutic strategies for the treatment of diseases, especially in indications with a high medical need. The experts of this team understand the importance of clinical investigations for the effective introduction and acceptance of new therapies. They manage and monitor all medical aspects of MorphoSys’s compounds in clinical trials, including the development of study protocols and reports. They also assess the potential development of an area of research.
At the Clinical Operations and the respective business teams, clinical monitoring and project management come together to ensure fast, successful, and scientifically sound project deliverables for MorphoSys’s compounds.
The experts at Clinical Operations strive to maximize the performance, clinical excellence, data integrity and product safety of MorphoSys’s programs. A team of scientists with a medical and pharmaceutical background oversees the development of clinical programs and the implementation of trials. They work in close collaboration with the Clinical Research and Preclinical Development departments on the selection of compound-specific target indications.